161 related articles for article (PubMed ID: 28080157)
1. Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.
Jeppesen MM; Mogensen O; Hansen DG; Iachina M; Korsholm M; Jensen PT
Acta Oncol; 2017 Feb; 56(2):262-269. PubMed ID: 28080157
[TBL] [Abstract][Full Text] [Related]
2. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
3. Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis.
Carrara L; Gadducci A; Landoni F; Maggino T; Scambia G; Galletto L; Lissoni AA; Fuso L; Zola P; Sartori E
Int J Gynecol Cancer; 2012 Jul; 22(6):1013-9. PubMed ID: 22706226
[TBL] [Abstract][Full Text] [Related]
4. Recurrence patterns and surveillance for patients with early stage endometrial cancer.
Salani R; Nagel CI; Drennen E; Bristow RE
Gynecol Oncol; 2011 Nov; 123(2):205-7. PubMed ID: 21820709
[TBL] [Abstract][Full Text] [Related]
5. Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer.
Jeppesen MM; Jensen PT; Hansen DG; Christensen RD; Mogensen O
BJOG; 2018 Dec; 125(13):1705-1714. PubMed ID: 29978593
[TBL] [Abstract][Full Text] [Related]
6. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Bristow RE; Purinton SC; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL
Gynecol Oncol; 2006 Nov; 103(2):709-13. PubMed ID: 16797686
[TBL] [Abstract][Full Text] [Related]
8. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of risk factors for recurrence after treatment of endometrial uterine cancer].
Zalewski K; Rzepka J; Madry R; Dańska-Bidzińska A; Bidzinski M
Ginekol Pol; 2009 Sep; 80(9):687-93. PubMed ID: 19886243
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up.
Ueda Y; Enomoto T; Egawa-Takata T; Miyatake T; Yoshino K; Fujita M; Matsuzaki S; Yokoyama T; Miyoshi Y; Kimura T
Int J Clin Oncol; 2010 Aug; 15(4):406-12. PubMed ID: 20425132
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.
Kiran G; Kesterson JP; Ozerkan K; Kanis M; Groman A; Lele S
Eur J Gynaecol Oncol; 2013; 34(6):522-6. PubMed ID: 24601043
[TBL] [Abstract][Full Text] [Related]
12. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study.
Cicinelli E; Tinelli R; Colafiglio G; Fortunato F; Fusco A; Mastrolia S; Fucci AR; Lepera A
Menopause; 2010; 17(3):511-5. PubMed ID: 20081548
[TBL] [Abstract][Full Text] [Related]
13. Surveillance procedures for patients treated for endometrial cancer: a review of the literature.
Sartori E; Pasinetti B; Chiudinelli F; Gadducci A; Landoni F; Maggino T; Piovano E; Zola P
Int J Gynecol Cancer; 2010 Aug; 20(6):985-92. PubMed ID: 20683406
[TBL] [Abstract][Full Text] [Related]
14. Follow-up after primary therapy for endometrial cancer: a systematic review.
Fung-Kee-Fung M; Dodge J; Elit L; Lukka H; Chambers A; Oliver T;
Gynecol Oncol; 2006 Jun; 101(3):520-9. PubMed ID: 16556457
[TBL] [Abstract][Full Text] [Related]
15. Costs and benefits of routine follow-up after curative treatment for endometrial cancer.
Agboola OO; Grunfeld E; Coyle D; Perry GA
CMAJ; 1997 Oct; 157(7):879-86. PubMed ID: 9327795
[TBL] [Abstract][Full Text] [Related]
16. Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125.
Lee JY; Kim JH; Seo JW; Kim HS; Kim JW; Park NH; Song YS
Int J Gynecol Cancer; 2016 Oct; 26(8):1434-9. PubMed ID: 27465903
[TBL] [Abstract][Full Text] [Related]
17. Post treatment surveillance of type II endometrial cancer patients.
Zakhour M; Li AJ; Walsh CS; Cass I; Karlan BY; Rimel BJ
Gynecol Oncol; 2013 Dec; 131(3):609-12. PubMed ID: 24051222
[TBL] [Abstract][Full Text] [Related]
18. A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.
Bendifallah S; Canlorbe G; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2014 Dec; 21(13):4239-45. PubMed ID: 24969441
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group study.
Namazov A; Helpman L; Eitan R; Vaknin Z; Lavie O; Ben-Arie A; Amit A; Levy T; Volodarsky M; Atlas I; Bruchim I; Gemer O
Maturitas; 2021 Jun; 148():18-23. PubMed ID: 34024347
[TBL] [Abstract][Full Text] [Related]
20. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
